NCT06587412

Brief Summary

Lateral epicondylalgia (LET) is characterized by pain, decreased muscle strength of the wrist extensor muscles, and disability. Among the treatments proposed in the literature, both focal shockwave therapy and radial shockwave therapy have been considered effective in the management of this musculoskeletal disorder. The objective of this study is to compare the safety and effectiveness of these two shockwave applications on the signs and symptoms of subjects with lateral epicondylalgia. In this clinical trial, subjects will be evaluated for elbow pain using a Visual Analog Scale (VAS), grip strength using a handheld dynamometer, and degree of disability using the Patient-Rated Tennis Elbow Evaluation Questionnaire (PRTEE). A six-month follow-up will be performed. Patients will be randomly divided into three groups. The first group will receive radial shock waves (rESWT), the second group will receive focal shock waves (fESWT), and the third group, which will act as a control, will receive a placebo treatment with very low energy parameters according to the literature. Subjects will receive three sessions, one session per week.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
14mo left

Started Mar 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress51%
Mar 2025Jun 2027

First Submitted

Initial submission to the registry

September 4, 2024

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

March 12, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2026

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2027

Expected
Last Updated

May 1, 2026

Status Verified

April 1, 2026

Enrollment Period

1.1 years

First QC Date

September 4, 2024

Last Update Submit

April 27, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain with Visual Analogue Scale (VAS)

    The pain VAS is a unidimensional measure of pain intensity, used to record patients' pain progression. VAS is a straight horizontal line of fixed length, usually 100 mm. The ends are defined as the extreme limits of the parameter to be measured where "0" on the far left is no pain and "10" on the far right is the worst pain possible.

    Change from Baseline pain at 6 month

Secondary Outcomes (3)

  • Grip strength

    Change from Baseline pain at 6 month

  • Patient Rated Tennis Elbow Evaluation (PRTEE)

    Change from Baseline pain at 6 month

  • The Global Rating of Change (GROC)

    Change from Baseline pain at 6 month

Study Arms (3)

Radial Shock Wave Treatment

EXPERIMENTAL

Patients assigned to this group will receive three sessions. During each session, 2000 pulses will be administered using a radial shock wave generator, with a pressure of 2.5 bars and a frequency of 8 Hz.

Other: Radial shock waves treatment

Focal Shock Wave Treatment

EXPERIMENTAL

Patients assigned to this group will receive three sessions. During each session, 2000 pulses will be delivered by a focal shock wave generator, with an energy flux density of 0.2 mJ/mm² and a frequency of 4 Hz.

Other: Focal Shock Waves treatment

Placebo Shock Waves

PLACEBO COMPARATOR

Subjects in this group will receive a placebo treatment with very low energy settings, designed to simulate therapy without offering real therapeutic effects. This group will receive 20 pulses per session, with an energy flux density of 0.08 mJ/mm².

Other: shock waves placebo treatment

Interventions

Subjects in this group will receive radial shock waves

Radial Shock Wave Treatment

Subjects in this group will receive focal shock waves

Focal Shock Wave Treatment

Subjects in this group will receive a shock waves placebo treatment with very low energy settings

Placebo Shock Waves

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Pain in the lateral epicondyle \>3 months
  • Pain when performing resisted grip
  • Positive Cozen test
  • Positive Maudsley test

You may not qualify if:

  • Pregnancy
  • Systemic diseases (Fibromyalgia, Diabetes, Arthritis)
  • Local infection or Cancer
  • Recent treatments (Physiotherapy, Corticosteroids)-

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centro Investigación Fisioterapia y Dolor

Alcalá de Henares, Madrid, 28806, Spain

RECRUITING

MeSH Terms

Conditions

Tennis Elbow

Condition Hierarchy (Ancestors)

Elbow TendinopathyTendinopathyMuscular DiseasesMusculoskeletal DiseasesElbow InjuriesArm InjuriesWounds and InjuriesTendon Injuries

Central Study Contacts

Yanira Rodriguez-García, Master

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 4, 2024

First Posted

September 19, 2024

Study Start

March 12, 2025

Primary Completion

April 20, 2026

Study Completion (Estimated)

June 20, 2027

Last Updated

May 1, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations